Susana Sousa

Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial

Susan Dent, Javier Cortés, Young‐Hyuck Im et al. · Annals of Oncology · 2020 · 163 citations · Full text

Medicine, Oncology, Pharmacology +15

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study

Joyce O’Shaughnessy, Susana Sousa, Josefina Cruz et al. · European Journal of Cancer · 2021 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Variant Rett syndrome in a girl with a pericentric X‐chromosome inversion leading to epigenetic changes and overexpression of the <i>MECP2</i> gene

José Pedro Vieira, Fátima Lopes, Anabela Silva‐Fernandes et al. · International Journal of Developmental Neuroscience · 2015 · 45 citations · Full text

Life Sciences, Genetics, Cytogenetics +14

Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?

Joana Cristo Santos, Miguel Henriques Abreu, Miriam Seoane Santos et al. · The Oncologist · 2023 · 25 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects

Ana Peixoto, Pedro Pinto, Joana Guerra et al. · Frontiers in Oncology · 2020 · 22 citations · Full text

Medicine, Genetics, Oncology +17